Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-29428
Publication type: | Article in scientific journal |
Type of review: | Peer review (publication) |
Title: | To what degree patient-reported symptoms of central sensitization, kinesiophobia, disability, sleep, and life quality associated with 24-h heart rate variability and actigraphy measurements? |
Authors: | Mikkonen, Jani Kupari, Saana Tarvainen, Mika Neblett, Randy Airaksinen, Olavi Luomajoki, Hannu Leinonen, Ville |
et. al: | No |
DOI: | 10.1111/papr.13331 10.21256/zhaw-29428 |
Published in: | Pain Practice |
Volume(Issue): | 24 |
Issue: | 4 |
Page(s): | 609 |
Pages to: | 619 |
Issue Date: | 12-Dec-2023 |
Publisher / Ed. Institution: | Wiley |
ISSN: | 1530-7085 1533-2500 |
Language: | English |
Subjects: | Actigraphy; Breathing rate; Central sensitization; Chronic musculoskeletal pain; Heart rate variability; Kinesiophobia; Patient-reported outcome measure; Sleep quality |
Subject (DDC): | 616.7: Diseases of musculoskeletal system and orthopaedics |
Abstract: | Objectives: Chronic musculoskeletal pain is associated with decreased parasympathetic and increased sympathetic activity in the autonomic nervous system. The objective of this study was to determine the associations between objective measures of heart rate variability (a measure of autonomic nervous system function), actigraphy (a measure of activity and sleep quality), respiration rates, and subjective patient-reported outcome measures (PROMs) of central sensitization, kinesiophobia, disability, the effect of pain on sleep, and life quality. Methods: Thirty-eight study subjects were divided into two subgroups, including low symptoms of central sensitization (n = 18) and high symptoms of central sensitization (n = 20), based on patient-reported scores on the Central Sensitization Inventory (CSI). Heart rate variability (HRV) and actigraphy measurements were carried out simultaneously in 24 h measurement during wakefulness and sleep. Results: A decrease in HRV during the first 2 h of sleep was stronger in the low CSI subgroup compared to the high CSI subgroup. Otherwise, all other HRV and actigraphy parameters and subjective measures of central sensitization, disability, kinesiophobia, the effect of pain on sleep, and quality of life showed only little associations. Discussion: The high CSI subgroup reported significantly more severe symptoms of disability, kinesiophobia, sleep, and quality of life compared to the low CSI subgroup. However, there were only small and nonsignificant trend in increased sympathetic nervous system activity and poorer sleep quality on the high central sensitization subgroup. Moreover, very little differences in respiratory rates were found between the groups. |
URI: | https://digitalcollection.zhaw.ch/handle/11475/29428 |
Fulltext version: | Published version |
License (according to publishing contract): | CC BY 4.0: Attribution 4.0 International |
Departement: | School of Health Sciences |
Organisational Unit: | Institute of Physiotherapy (IPT) |
Appears in collections: | Publikationen Gesundheit |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2023_Mikkonen-etal_Patient‐reported-symptoms-24h-heart-rate-variability.pdf | 1.42 MB | Adobe PDF | View/Open |
Show full item record
Mikkonen, J., Kupari, S., Tarvainen, M., Neblett, R., Airaksinen, O., Luomajoki, H., & Leinonen, V. (2023). To what degree patient-reported symptoms of central sensitization, kinesiophobia, disability, sleep, and life quality associated with 24-h heart rate variability and actigraphy measurements? Pain Practice, 24(4), 609–619. https://doi.org/10.1111/papr.13331
Mikkonen, J. et al. (2023) ‘To what degree patient-reported symptoms of central sensitization, kinesiophobia, disability, sleep, and life quality associated with 24-h heart rate variability and actigraphy measurements?’, Pain Practice, 24(4), pp. 609–619. Available at: https://doi.org/10.1111/papr.13331.
J. Mikkonen et al., “To what degree patient-reported symptoms of central sensitization, kinesiophobia, disability, sleep, and life quality associated with 24-h heart rate variability and actigraphy measurements?,” Pain Practice, vol. 24, no. 4, pp. 609–619, Dec. 2023, doi: 10.1111/papr.13331.
MIKKONEN, Jani, Saana KUPARI, Mika TARVAINEN, Randy NEBLETT, Olavi AIRAKSINEN, Hannu LUOMAJOKI und Ville LEINONEN, 2023. To what degree patient-reported symptoms of central sensitization, kinesiophobia, disability, sleep, and life quality associated with 24-h heart rate variability and actigraphy measurements? Pain Practice. 12 Dezember 2023. Bd. 24, Nr. 4, S. 609–619. DOI 10.1111/papr.13331
Mikkonen, Jani, Saana Kupari, Mika Tarvainen, Randy Neblett, Olavi Airaksinen, Hannu Luomajoki, and Ville Leinonen. 2023. “To What Degree Patient-Reported Symptoms of Central Sensitization, Kinesiophobia, Disability, Sleep, and Life Quality Associated with 24-H Heart Rate Variability and Actigraphy Measurements?” Pain Practice 24 (4): 609–19. https://doi.org/10.1111/papr.13331.
Mikkonen, Jani, et al. “To What Degree Patient-Reported Symptoms of Central Sensitization, Kinesiophobia, Disability, Sleep, and Life Quality Associated with 24-H Heart Rate Variability and Actigraphy Measurements?” Pain Practice, vol. 24, no. 4, Dec. 2023, pp. 609–19, https://doi.org/10.1111/papr.13331.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.